Close
  Indian J Med Microbiol
 

Figure 3: The relationship between MAGI-2 expression and patient prognosis. Kaplan–Meier analysis of (a) disease-free survival in patient data retrieved from TCGA database (n = 495, P = 0.0556), (b) BCR-free survival analysis (n = 179, P = 0.0041), and (c) PCa-specific overall survival (n = 208, P = 0.8863) of patients enrolled in tissue microarray. (d) Correlation between MAGI-2 expression and tumor recurrent in GEO dataset. MAGI-2: membrane-associated guanylate kinase (MAGUK) family protein MAGUK invert 2; BCR: biochemical recurrence; PCa: prostate cancer; GEO: Gene Expression Omnibus.

Figure 3: The relationship between MAGI-2 expression and patient prognosis. Kaplan–Meier analysis of (<b>a</b>) disease-free survival in patient data retrieved from TCGA database (<i>n</i> = 495, <i>P</i> = 0.0556), (<b>b</b>) BCR-free survival analysis (<i>n</i> = 179, <i>P</i> = 0.0041), and (<b>c</b>) PCa-specific overall survival (<i>n</i> = 208, <i>P</i> = 0.8863) of patients enrolled in tissue microarray. (<b>d</b>) Correlation between MAGI-2 expression and tumor recurrent in GEO dataset. MAGI-2: membrane-associated guanylate kinase (MAGUK) family protein MAGUK invert 2; BCR: biochemical recurrence; PCa: prostate cancer; GEO: Gene Expression Omnibus.